Rumble Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Rumble Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $100.62M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $95.49M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $80.96M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $39.38M | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | $9.47M | Mar 30, 2023 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $39.38M | Mar 30, 2023 |
| FY2022 | Dec 31, 2021 | $9.47M | Mar 30, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($81.83M) | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | ($338.36M) | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | ($116.42M) | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | ($11.40M) | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | ($13.41M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($1.3K) | Mar 24, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($126.65M) | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | ($130.85M) | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | ($135.55M) | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | ($35.60M) | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | ($10.51M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($1.3K) | Mar 24, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.74M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $18.92M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $15.72M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $6.34M | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | $1.62M | Mar 30, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($70.43M) | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | ($87.01M) | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | ($92.91M) | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | ($32.29M) | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | ($5.31M) | Mar 30, 2023 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.07M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $2.67M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $14.57M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $8.54M | Mar 27, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $336.85M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $195.31M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $295.71M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $366.98M | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | $55.80M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $205.8K | Mar 24, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $62.00M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $258.43M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $44.09M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $27.35M | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | $8.64M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $182.1K | Mar 24, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $274.84M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | ($63.12M) | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | $251.62M | Mar 5, 2026 |
| FY2024 | Dec 31, 2022 | $339.63M | Mar 25, 2025 |
| FY2023 | Dec 31, 2021 | $30.37M | Mar 27, 2024 |
| FY2022 | Dec 31, 2020 | ($340.9K) | Mar 30, 2023 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.66M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $10.66M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $10.66M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $662.9K | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | $662.9K | Mar 30, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($565.40M) | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | ($483.57M) | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | ($145.20M) | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | ($28.78M) | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | ($17.38M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($1.3K) | Mar 24, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $237.92M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $114.02M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $218.34M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $337.17M | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | $46.85M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $25.0K | Mar 24, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 30, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 30, 2023 |